Improving outcomes in patients with non-tuberculous mycobacterial disease: is there light at the end of the tunnel?

Keertan Dheda^{1

2}

Affiliations

¹ Centre for Lung Infection and Immunity, Division of Pulmonology, Dept of Medicine and UCT Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa keertan.dheda@uct.ac.za.
² Faculty of Infectious and Tropical Diseases, Dept of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.

Free article

Editorial

Keertan Dheda. Eur Respir J. 2019.

Free article

. 2019 Jul 11;54(1):1901149.

doi: 10.1183/13993003.01149-2019. Print 2019 Jul.

Keertan Dheda^{1

2}

¹ Centre for Lung Infection and Immunity, Division of Pulmonology, Dept of Medicine and UCT Lung Institute and South African MRC/UCT Centre for the Study of Antimicrobial Resistance, University of Cape Town, Cape Town, South Africa keertan.dheda@uct.ac.za.
² Faculty of Infectious and Tropical Diseases, Dept of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK.

No abstract available

Comment on

M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.
Kwak N, Dalcolmo MP, Daley CL, Eather G, Gayoso R, Hasegawa N, Jhun BW, Koh WJ, Namkoong H, Park J, Thomson R, van Ingen J, Zweijpfenning SMH, Yim JJ. Kwak N, et al. Eur Respir J. 2019 Jul 11;54(1):1801991. doi: 10.1183/13993003.01991-2018. Print 2019 Jul. Eur Respir J. 2019. PMID: 30880280
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease.
Zweijpfenning SMH, Schildkraut JA, Coolen JPM, Ruesen C, Koenraad E, Janssen A, Ruth MM, de Jong AS, Kuipers S, Aarnoutse RE, Magis-Escurra C, Hoefsloot W, van Ingen J. Zweijpfenning SMH, et al. Eur Respir J. 2019 Jul 11;54(1):1900118. doi: 10.1183/13993003.00118-2019. Print 2019 Jul. Eur Respir J. 2019. PMID: 31000671 No abstract available.